InhaleRx Limited (IRX.AX)
- Previous Close
0.0300 - Open
0.0370 - Bid 0.0210 x --
- Ask 0.0370 x --
- Day's Range
0.0300 - 0.0370 - 52 Week Range
0.0200 - 0.0500 - Volume
3,003 - Avg. Volume
26,763 - Market Cap (intraday)
5.693M - Beta (5Y Monthly) -0.74
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Aug 20, 2024 - Aug 26, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Melbourne, Australia.
inhalerx.com.auRecent News: IRX.AX
Performance Overview: IRX.AX
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IRX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IRX.AX
Valuation Measures
Market Cap
5.69M
Enterprise Value
5.54M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
8.55
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-119.87%
Return on Assets (ttm)
-46.40%
Return on Equity (ttm)
-112.39%
Revenue (ttm)
1.2M
Net Income Avi to Common (ttm)
-1.44M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
715.82k
Total Debt/Equity (mrq)
84.19%
Levered Free Cash Flow (ttm)
-1.59M